Table 1.
Dendrimer | t[NO] (μmol NO/mg)a | t[NO] (μmol NO/μmol)b | [NO]max (ppb/mg)c | [NO]max (ppb/μmol)d | t½ (h) | Conversion (%) | |
---|---|---|---|---|---|---|---|
a-8-NO | G2-PPI-ACN-NO | 3.57 | 4.18 | 1529 | 1788 | 4.81 | 26.1 |
a-16-NO | G3-PPI-ACN-NO | 3.33 | 8.35 | 1100 | 2758 | 4.84 | 26.1 |
a-32-NO | G4-PPI-ACN-NO | 2.45 | 12.7 | 1547 | 7977 | 4.82 | 19.9 |
a-64-NO | G5-PPI-ACN-NO | 1.68 | 17.7 | 881 | 9282 | 4.88 | 13.8 |
| |||||||
b-8-NO | G2-PPI-PEG-NO | 1.11 | 5.10 | 3771 | 17291 | 0.67 | 31.9 |
b-16-NO | G3-PPI-PEG-NO | 1.08 | 10.1 | 2309 | 21564 | 1.11 | 31.6 |
b-32-NO | G4-PPI-PEG-NO | 1.37 | 25.8 | 4088 | 77035 | 0.84 | 40.3 |
b-64-NO | G5-PPI-PEG-NO | 1.17 | 44.3 | 1886 | 71403 | 1.22 | 34.6 |
| |||||||
c-8-NO | G2-PPI-PO-NO | 2.99 | 3.63 | 17130 | 20725 | 0.30 | 22.7 |
c-16-NO | G3-PPI-PO-NO | 3.22 | 8.38 | 9617 | 24888 | 0.62 | 26.2 |
c-32-NO | G4-PPI-PO-NO | 3.27 | 17.5 | 7762 | 41481 | 0.78 | 27.3 |
c-64-NO | G5-PPI-PO-NO | 3.78 | 41.1 | 6839 | 74250 | 1.06 | 32.1 |
| |||||||
d-8-NO | G2-PPI-SO-NO | 1.14 | 1.95 | 8495 | 14496 | 1.47 | 12.2 |
d-16-NO | G3-PPI-SO-NO | 0.91 | 3.30 | 2363 | 8462 | 0.97 | 10.3 |
d-32-NO | G4-PPI-SO-NO | 1.18 | 8.70 | 1720 | 12609 | 1.43 | 13.6 |
d-64-NO | G5-PPI-SO-NO | 1.25 | 18.5 | 2215 | 32843 | 1.62 | 14.5 |
| |||||||
e-8-NO | G2-PPI-ED-NO | 1.95 | 3.87 | 5648 | 11178 | 0.81 | 24.2 |
e-16-NO | G3-PPI-ED-NO | 1.64 | 6.75 | 2733 | 11279 | 1.71 | 21.1 |
e-32-NO | G4-PPI-ED-NO | 1.51 | 12.8 | 2401 | 20217 | 1.34 | 19.9 |
e-64-NO | G5-PPI-ED-NO | 1.86 | 31.6 | 3190 | 54262 | 1.88 | 24.7 |
total amount of NO release (μmol) per milligram of secondary amine-functionalized PPI.
total amount of NO release (μmol) per micromole of secondary amine-functionalized PPI.
maximum flux of NO release (ppb) per milligram of secondary amine-functionalized PPI.
maximum flux of NO release (ppb) per micromole of secondary amine-functionalized PPI.